精确医学在心律失常的管理中
Felix Wiedmann1,2, Constanze Schmidt3,4
1Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Herz
|March 8, 2025
概括
精准医学通过根据个体遗传和生活方式因素量身定制治疗来彻底改变心脏电生理学. 这种个性化的方法可以改善诊断和预防长QT综合征等疾病.
科学领域:
- 心血管医学 心血管医学
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 传统的心脏电生理学经常使用一般化策略.
- 精准医学结合了遗传,环境和生活方式因素,以提供个性化的护理.
- 在通过遗传洞察来管理道病变方面,已经取得了重大进展.
研究的目的:
- 探索精准医学在心脏电生理学中的作用和进步.
- 突出个性化方法如何改善心律失常的诊断,治疗和预防.
- 讨论影响该领域的新兴技术.
主要方法:
- 集成大数据 (临床记录,omics,CIED/可穿戴设备的生物信号).
- 利用人类诱导的多能干细胞 (hiPSCs) 和in silico建模进行功能评估.
- 在复杂疾病中使用全基因组关联研究 (GWAS) 和多基因风险评分 (PRS).
主要成果:
- 遗传洞察力正在推动道病变的个性化疗法,改善长QT综合征等疾病的结果.
- 大数据集成和先进的建模显示,有可能彻底改变心律失常的诊断.
- GWAS和PRS增强了对心律失常症的风险分层和治疗策略.
结论:
- 精准医学为心律失常提供量身定制的诊断,治疗和预防策略.
- 像CRISPR/Cas9这样的新兴技术对遗传性和获得性心律失常的基因编辑具有前途.
- 个性化的患者特征是推动心脏电生理学护理的关键.
相关概念视频
Disturbances in Heart Rhythm
842
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
842
Mechanism of Cardiac Arrhythmias
867
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
867
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
879
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
879
Pulse rhythm
749
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
749
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
695
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
695
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
749
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
749


